Espicom Business Intelligence Ltd, July 2011, Pages: 300
pharmaceuticaltechnology companies in leading emerging markets such as India, China, Brazil and Russia?
Which other business reference provides...
- Key economic, demographic and health statistics on 66
GBI Research, Nov 2011, Pages: 68
GBI Research, the leading businessintelligence provider, has released its latest research “Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being
Espicom Business Intelligence Ltd, Nov 2011
and recombinant proteins.
THESE REPORTS ANALYSE THE ISSUES
The The Outlook for Pharmaceuticals in Central & Eastern Europe is a unique collection of management reports from Espicom BusinessIntelligence. Each
GBI Research, Feb 2012, Pages: 75
GBI Research, the leading businessintelligence provider, has released its latest research “Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain
Business Monitor International, Jan 2011, Pages: 108
And Healthcare Industry SWOT
- UK Political SWOT
- UK Economic SWOT
PharmaceuticalBusiness Environment Ratings
Table: Western EuropePharmaceuticalsBusiness Environment Ratings For Q111
- Risks
UK
HBS Consulting, June 2006, Pages: 113
: (1) regulation of prices (especially relevant to pharmaceuticals), input resources, and health care service volumes (2) shifts of costs onto the private sector and (3) caps on health spending, either
Infiniti Research Limited, Oct 2008, Pages: 19
products.
The report forecasts the IT spending of the Manufacturing Industry in Europe over the period 2007-2010. It is meant for IT vendors and intends to help them identify selling opportunities
Business Monitor International, Nov 2010, Pages: 89
and capped government spending. Executive Summary
SWOT Analysis
Hungary Pharmaceuticals And Healthcare Industry SWOT
Hungary Political SWOT
Hungary Economic SWOT
Hungary Business Environment SWOT
Arrowhead Publishers, March 2006, Pages: 209
of pharmaceuticals and healthcare. She has held
industry research positions at IMS Health, Business Monitor International and World Markets Health Centre
(Global Insight).
She has been responsible for providing
Business Monitor International, May 2010, Pages: 85
with independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry.
BMI’s Pharmaceuticals & Healthcare Business Environment Ratings for Q310 put Poland as the second most
Primary Research Group, Sep 2010, Pages: 198
years. 64% in the pharmaceutical sector said that they had become more involved.
- Per employee spending was by far the highest in research, consulting, law, finance and other business services. LIST
